Official information request details
The number of clinical drug trials your DHB hosted in the 2017/2018 financial year + ongoing trials in 2019. Could figures please be broken-down by:
- The number of sponsored clinical trials involving devices and pharmaceuticals.
- Phase 1 first-man-in clinical trials and phase 2a/b safety and efficacy trials, phase 3 broader efficacy trials and phase 4 post-marketing surveillance. And whether these trials are investigator-initiated or industry-sponsored commercially contracted trials.
- Investigator-initiated studies of non-therapeutic interventions, e.g. new diagnostics or new applications of existing diagnostics.
- Investigator-initiated observational studies including epidemiologic studies.
- Can you please also provide the aggregate income figure your DHB obtained from trials conducted in the 2017/2018 financial year.
